| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 88.2% | 15/17 |
| Female | 11.8% | 2/17 |
| Indifferent | 0% | 0/17 |
| Unknown | 0% | 0/17 |
| General | ||
| Birth Length | 0% | 0/17 |
| 5.9% | 1/17 | |
| Birth Head circumference | 0% | 0/17 |
| Current Height | 0% | 0/17 |
| Current Weight | 0% | 0/17 |
| Current Head circumference | 0% | 0/17 |
| 94.1% | 16/17 | |
| 94.1% | 16/17 | |
| 82.4% | 14/17 | |
| 85.7% | 12/14 | |
| Neurology | ||
| 94.1% | 16/17 | |
| 82.4% | 14/17 | |
| 52.9% | 9/17 | |
| Facial abnormalities | ||
| 47.1% | 8/17 | |
| 17.6% | 3/17 | |
| 5.9% | 1/17 | |
| 17.6% | 3/17 | |
| Visual and hearing impairments | ||
| 5.9% | 1/17 | |
| 23.5% | 4/17 | |
| Heart | ||
| Abnormality of the heart | 0% | 0/17 |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/17 |
| Gastrointestinal | ||
| Gastrointestinal | 0% | 0/17 |
| Urogenital | ||
| Urogenital | 0% | 0/17 |
| Skeleton | ||
| 11.8% | 2/17 | |
| Skin / Hair / Nails | ||
| 5.9% | 1/17 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/17 |
| Metabolic | 0% | 0/17 |
| Immune | 0% | 0/17 |
| Neoplasia | ||
| Neoplasia | 0% | 0/17 |
| Inheritance | ||
| 52.9% | 9/17 | |
ARFGEF1